NCT04984551RecruitingPhase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
ECHO Telementoring to Improve Quality Palliative Care in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
Source: ClinicalTrials.gov · Last updated 14 Sept 2026
Brief summary (registry, in English)
This trial investigates the experience and satisfaction of care in patients with cancer that has spread to other places in the body (advanced) and their caregivers living in underserved areas of Kenya, Nigeria, Ghana, South Africa, India and Ethiopia as part of Project Extension for Community Healthcare Outcomes (ECHO). Project ECHO is a model of medical education and care management that empowers clinicians to provide better care to more people where they live. Understanding the experiences and satisfaction of patients and caregivers may help improve healthcare workforce capacity and increase access to specialty care for the world's rural and underserved populations.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 312 (estimated)
- First submitted
- 27 Aug 2020
- Start date
- 24 Aug 2020
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Childhood cancers
- NCT number
- NCT04984551
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 312
- From 24 Aug 2020 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unable to understand and sign consent
Who the study is looking for
- PATIENT: Scheduled to receive treatment at participating primary care practice for advanced cancer
- PATIENT: 18 years or older
- PATIENT: Willing to be accessible to the research team for follow-up by telephone or in person
- PATIENT: Prognosis of at least 1 year as ascertained by the treating physician
- PATIENT: Able to read and understand English as assessed by the treating physician
- CAREGIVER: Identified or self-identified as primary caregiver of the patient
- CAREGIVER: Willing to be accessible to the research team for follow-up by telephone or in person
- CAREGIVER: 18 years or older
- CAREGIVER: Able to read and understand English as assessed by the treating physician
- ECHO PARTICIPANT: Participant must be a health care provider interested to participate in the study for 2 years and understand the protocol and provide consent
- ECHO PARTICIPANT: Able to read and understand English as assessed by principal investigator (PI)
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.